Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics
Proceedings of a Workshop
Häftad, Engelska, 2024
Av and Medicine National Academies of Sciences, Engineering, Health and Medicine Division, Board on Health Sciences Policy, and Translation Forum on Drug Discovery, Development, Board on Health Care Services, National Cancer Policy Forum, National Academies of Sciences Engineeri, National Academies of Sciences Engineering and Medicine, Health And Medicine Division, Board On Health Sciences Policy, Forum on Drug Discovery Development and Translation, Board On Health Care Services, Sharyl Nass, Anne Frances Johnson, Jennifer Zhu, Erin Balogh
389 kr
Tillfälligt slut
The use of immune modulator therapeutics, a type of immunotherapy enhancing the body immune system response to cancer, was perceived as the beginning of a new era in cancer care. While still important and frequently used, some of these therapeutics produce uneven response rates, disease resistance, and serious side effects. The National Academies National Cancer Policy Forum, in collaboration with the Forum on Drug Discovery, Development, and Translation, hosted a public workshop to discuss challenges related to immunotherapy treatment resistance, as well as potential policy opportunities to improve the development of immunotherapies for cancer treatment.Table of ContentsFront MatterProceedings of a WorkshopAppendix A: Statement of TaskAppendix B: Workshop Agenda
Produktinformation
- Utgivningsdatum2024-08-29
- Mått152 x 229 x undefined mm
- FormatHäftad
- SpråkEngelska
- Antal sidor86
- FörlagNational Academies Press
- ISBN9780309716260